Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...

Researchers from Mayo Clinic trained and tested the AI tool on more than 3,600 scans, including images from patients with ...

New research finds that diet, exercise, and stress management helped improve or stabilize brain function in early-stage ...

Semaglutide, the active ingredient in diabetes medications Ozempic and Wegovy, was associated with a significantly reduced ...

A widely-used supplement among gym enthusiasts may hold the key to lowering the risk of developing Alzheimer's disease, ...

The AI tool, StateViewer, helped researchers identify a person’s dementia type in 88% of cases, according to results newly ...

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity ...

Scientists have identified a simple blood test that measures insulin resistance which may also help doctors determine which ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

The research indicated that those with cataracts and systemic conditions were up to 2.29 times more likely to develop ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

A massive U.S. study found diabetics on semaglutide (Ozempic’s active ingredient) had up to 70% lower risk of ...